Spyre Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Spyre Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2016 to Q3 2024.
  • Spyre Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -51 %, a 75.1% increase year-over-year.
  • Spyre Therapeutics, Inc. annual Return On Assets for 2023 was -160 %, a 68.6% decline from 2022.
  • Spyre Therapeutics, Inc. annual Return On Assets for 2022 was -95.1 %, a 98.5% decline from 2021.
  • Spyre Therapeutics, Inc. annual Return On Assets for 2021 was -47.9 %, a 17.9% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -51 +154 +75.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -50.5 +187 +78.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -114 -17.1 -17.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -160 -65.3 -68.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -205 -118 -135% Jul 1, 2023 Sep 30, 2023
Q2 2023 -238 -156 -191% Apr 1, 2023 Jun 30, 2023
Q1 2023 -96.7 -35.3 -57.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -95.1 -47.2 -98.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -87.3 -42 -92.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -81.6 -39.7 -94.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -61.4 -12.2 -24.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -47.9 +10.4 +17.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -45.3 +21.6 +32.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -41.9 +37.2 +47% Apr 1, 2021 Jun 30, 2021
Q1 2021 -49.2 +38.2 +43.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -58.3 +14.6 +20% Oct 1, 2020 Dec 31, 2020
Q3 2020 -66.9 +0.74 +1.09% Jul 1, 2020 Sep 30, 2020
Q2 2020 -79.1 -16.3 -25.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -87.3 -27.6 -46.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -72.9 -9.22 -14.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -67.6 -11.7 -20.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -62.8 -10.9 -21.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -59.8 -9.92 -19.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -63.7 -19.2 -43.2% Oct 1, 2018 Dec 31, 2018
Q3 2018 -56 -15 -36.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -51.8 -15.1 -40.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -49.9 -16.2 -47.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -44.5 -10 -29.1% Oct 1, 2017 Dec 31, 2017
Q3 2017 -41 -4.85 -13.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -36.8 Apr 1, 2017 Jun 30, 2017
Q1 2017 -33.7 Jan 1, 2017 Mar 31, 2017
Q4 2016 -34.5 Oct 1, 2016 Dec 31, 2016
Q3 2016 -36.2 Jul 1, 2016 Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.